-- 山东博安生物技术有限公司（港交所代码：6955）周日向香港交易所提交的文件显示，该公司已获得中国监管机构的批准，将对其研发的BA1106肺癌二期临床试验进行审查。 周一早盘交易中，该公司股价上涨超过2%。 该公司正在寻求批准，将BA1106与另一款药物BA1104联合用于非小细胞肺癌的一线或二线治疗。
Related Articles
Australia
IonQ, Florida LambdaRail Launch Quantum-Safe Network Initiative
IonQ (IONQ) said Monday it entered an agreement with Florida LambdaRail to develop a nearly 100-mile quantum-safe network from Palm Beach County to Miami-Dade, connecting three research and education institutions.Phase 1 involves creating a three-node corridor linking select area colleges over the existing Florida LambdaRail fiber network before leveraging IonQ's quantum key distribution technology for protection against cyber threats, the company said.Upon completion of phase 1, the initiative is expected to expand across the Florida LambdaRail network, connecting additional institutions statewide, according to a statement.Price: $42.00, Change: $-0.70, Percent Change: -1.63%
$IONQ
Australia
TerrAscend Announces Preliminary First Quarter 2026 Financial Results
TerrAscend (TSND.TO), a North American cannabis operator, announced preliminary and unaudited financial results for the first quarter ended March 31, 2026, on Monday.The preliminary and unaudited financial results reported are from continuing operations, and do not include Michigan, which are reported as discontinued operations effective as of the second quarter ended June 30, 2025, said the company.For the first quarter of 2026, the company expects net revenue of US$65.5 million, compared to US$66.1 million in the fourth quarter of 2025 and US$64.3 million in the first quarter of 2025.It expects gross profit margin of 52.8% for the first quarter of 2026, compared to 52.1% in the fourth quarter of 2025 and 53.9% in the first quarter of 2025.The company's shares were last seen up C$0.03 or 3.3% at C$0.94 on the Toronto Stock Exchange.Price: $0.95, Change: $+0.04, Percent Change: +4.40%
$HMMJ.TO$TSND.TO
International
Dallas Fed April Manufacturing Index Indicates Faster Contraction
The Dallas Fed's monthly manufacturing index fell to a reading of minus 2.3 in April from minus 0.2 in March, compared with expectations for an increase to a reading of 0.8.The index indicates faster contraction, which is in contrast with other regional manufacturing readings already released, and the S&P global flash measure that suggested expansion.For Dallas, there were gains in the readings for production, shipments, new orders, employment and prices paid.The reading for the company outlook rebounded to 3.0 from minus 3.5 in March.